These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8391870)

  • 81. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists.
    Shattil SJ; Budzynski A; Scrutton MC
    Blood; 1989 Jan; 73(1):150-8. PubMed ID: 2535942
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets.
    Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A
    J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Antiplatelet effect of butylidenephthalide.
    Teng CM; Chen WY; Ko WC; Ouyang CH
    Biochim Biophys Acta; 1987 Jun; 924(3):375-82. PubMed ID: 3109495
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus.
    Brass LF; Vassallo RR; Belmonte E; Ahuja M; Cichowski K; Hoxie JA
    J Biol Chem; 1992 Jul; 267(20):13795-8. PubMed ID: 1321125
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin.
    Zhang J; Zhang J; Shattil SJ; Cunningham MC; Rittenhouse SE
    J Biol Chem; 1996 Mar; 271(11):6265-72. PubMed ID: 8626420
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Binding of a radioiodinated 13-azapinane thromboxane antagonist to platelets: correlation with antiaggregatory activity in different species.
    Narumiya S; Okuma M; Ushikubi F
    Br J Pharmacol; 1986 Jun; 88(2):323-31. PubMed ID: 3730697
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling.
    Brass LF; Pizarro S; Ahuja M; Belmonte E; Blanchard N; Stadel JM; Hoxie JA
    J Biol Chem; 1994 Jan; 269(4):2943-52. PubMed ID: 7507931
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Novel nonpeptide antiplatelet glycoprotein IIb/IIIa receptor antagonist, DMP754: receptor binding affinity and specificity.
    Mousa SA; Forsythe M; Lorelli W; Bozarth J; Xue CB; Wityak J; Sielecki TM; Olson RE; DeGrado W; Kapil R; Hussain M; Wexler R; Thoolen MJ; Reilly TM
    Coron Artery Dis; 1996 Oct; 7(10):767-74. PubMed ID: 8970768
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
    Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
    Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 Apr; 71(4):850-60. PubMed ID: 2833330
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation].
    Luk'ianenko EF; Kireeva EG; Strukova SM
    Biull Eksp Biol Med; 1988 Nov; 106(11):517-9. PubMed ID: 2848597
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling.
    Joseph S; MacDermot J
    Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):571-7. PubMed ID: 8383967
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF).
    Cargill DI; Cohen DS; Van Valen RG; Klimek JJ; Levin RP
    Thromb Haemost; 1983 Jun; 49(3):204-7. PubMed ID: 6879508
    [TBL] [Abstract][Full Text] [Related]  

  • 95. PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets.
    Henriksen RA; Hanks VK
    Arterioscler Thromb Vasc Biol; 2002 May; 22(5):861-6. PubMed ID: 12006403
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Distribution of ligand-occupied alpha IIb beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6.
    Nurden P; Humbert M; Piotrowicz RS; Bihour C; Poujol C; Nurden AT; Kunicki TJ
    Blood; 1996 Aug; 88(3):887-99. PubMed ID: 8704246
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Agonist receptors and G proteins as mediators of platelet activation.
    Brass LF; Hoxie JA; Kieber-Emmons T; Manning DR; Poncz M; Woolkalis M
    Adv Exp Med Biol; 1993; 344():17-36. PubMed ID: 8209785
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
    Nierodzik ML; Klepfish A; Karpatkin S
    Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
    [TBL] [Abstract][Full Text] [Related]  

  • 100. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
    Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
    Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.